Beta Bionics, Inc.
Nasdaq BBNX · Irvine, CA
Works in Immunology · Metabolic & endocrine
Beta Bionics, Inc. is a clinical trial sponsor based in Irvine, CA, listed as Nasdaq BBNX. It has 1 active clinical trial with 1,875 planned participants, in Immunology and Metabolic & endocrine. Its FDA record on file shows 1 warning letter.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq BBNX
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Beta Bionics, Inc
Yes. FDA has published 1 warning letter naming Beta Bionics, Inc; the latest was posted on 2026-02-24. Each letter links to FDA's own posting.
Beta Bionics, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 1,875 planned participants, in Immunology, Metabolic & endocrine. Since 2021 it has completed 0 trials and stopped 0 early.
Beta Bionics, Inc is based in Irvine, CA and is listed as Nasdaq BBNX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Beta Bionics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-08.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Beta Bionics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.